Risk scores are statistical indicators based on prescribing patterns compared to specialty peers. They are NOT allegations of fraud, misconduct, or improper care. Many legitimate medical reasons can explain outlier prescribing.
Read our methodology →Risk Flags
Risk indicators are statistical patterns, not allegations. Learn more
9,277
Total Claims
$702K
Drug Cost
832
Beneficiaries
$844
Cost/Patient
Risk Score Breakdown 9/100
Score components are additive. Read full methodology
Peer Comparison vs. 106,889 Family Practice providers
-57%
Opioid rate vs peers
1.1% vs 2.6% avg
-21%
Cost per patient vs peers
$844 vs $1,068 avg
+30%
Brand preference vs peers
11.7% vs 9.0% avg
⚠️ Opioid + Benzodiazepine Co-Prescriber
This provider prescribes both opioids and benzodiazepines. The FDA has issued a Black Box Warning about the life-threatening risks of concurrent use.
Opioid Prescribing
1.1%
Opioid Rate
104
Opioid Claims
$780
Opioid Cost
—
Long-Acting Rate
Brand vs Generic
Brand: 1,074 claims · $541K
Generic: 8,118 claims · $156K
Top Prescribed Drugs
| Drug (Generic) | Claims | Cost |
|---|---|---|
| Apixaban | 68 | $89K |
| Semaglutide | 50 | $58K |
| Insulin Glargine,hum.Rec.Anlog | 47 | $27K |
| Denosumab | 15 | $25K |
| Fluticasone/Umeclidin/Vilanter | 22 | $21K |
| Sitagliptin Phosphate | 13 | $20K |
| Budesonide/Formoterol Fumarate | 32 | $20K |
| Insulin Glargine,hum.Rec.Anlog | 21 | $18K |
| Rivaroxaban | 17 | $16K |
| Insulin Lispro | 33 | $16K |
| Mirabegron | 12 | $16K |
| Insulin Glargine,hum.Rec.Anlog | 20 | $12K |
| Fluticasone/Vilanterol | 13 | $9,825 |
| Atorvastatin Calcium | 713 | $9,392 |
| Fluticasone Propion/Salmeterol | 11 | $8,904 |
Prescribing Profile
Patient Profile
73
Avg Age
78%
Female
1.32
Avg Risk Score
Explore More
Data from CMS Medicare Part D Prescriber Public Use File, 2023. Risk scores are statistical indicators, not allegations.Methodology · About